[{"Assets_0_Q1_USD":1025448000.0,"CommonStockSharesOutstanding_0_Q1_shares":52374248.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":32993000.0,"NetIncomeLoss_1_Q1_USD":18340000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":52336443.0,"StockholdersEquity_0_Q1_USD":480018000.0,"EarningsPerShareBasic_1_Q1_USD":0.35,"Ticker":"SUPN","CIK":"1356576","name":"SUPERNUS PHARMACEUTICALS INC","OfficialName":"Supernus Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1557812380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190510"}]